Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies.

Yang K, Wang X, Zhang H, Wang Z, Nan G, Li Y, Zhang F, Mohammed MK, Haydon RC, Luu HH, Bi Y, He TC.

Lab Invest. 2016 Feb;96(2):116-36. doi: 10.1038/labinvest.2015.144. Epub 2015 Nov 30.

2.
3.

Can we safely target the WNT pathway?

Kahn M.

Nat Rev Drug Discov. 2014 Jul;13(7):513-32. doi: 10.1038/nrd4233. Review.

4.

Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Greiner AK, Papineni RV, Umar S.

Am J Physiol Gastrointest Liver Physiol. 2014 Jul 1;307(1):G1-15. doi: 10.1152/ajpgi.00044.2014. Epub 2014 May 1. Review.

5.

Targeting CSC-related miRNAs for cancer therapy by natural agents.

Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S, Banerjee S, Kong D, Sarkar FH.

Curr Drug Targets. 2012 Dec;13(14):1858-68. Review.

6.

Antiproliferative and cytotoxic effects of resveratrol in mitochondria-mediated apoptosis in rat b103 neuroblastoma cells.

Rahman MA, Kim NH, Kim SH, Oh SM, Huh SO.

Korean J Physiol Pharmacol. 2012 Oct;16(5):321-6. doi: 10.4196/kjpp.2012.16.5.321. Epub 2012 Oct 18.

7.

The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH.

Biochim Biophys Acta. 2012 Dec;1826(2):272-96. doi: 10.1016/j.bbcan.2012.04.008. Epub 2012 May 10. Review.

8.

Modulation of Wnt/╬▓-catenin signaling pathway by bioactive food components.

Tarapore RS, Siddiqui IA, Mukhtar H.

Carcinogenesis. 2012 Mar;33(3):483-91. doi: 10.1093/carcin/bgr305. Epub 2011 Dec 22. Review.

9.

Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.

Hussain AR, Uddin S, Bu R, Khan OS, Ahmed SO, Ahmed M, Al-Kuraya KS.

PLoS One. 2011;6(9):e24703. doi: 10.1371/journal.pone.0024703. Epub 2011 Sep 12.

10.

Self-renewal related signaling in myeloid leukemia stem cells.

Heidel FH, Mar BG, Armstrong SA.

Int J Hematol. 2011 Aug;94(2):109-17. doi: 10.1007/s12185-011-0901-0. Epub 2011 Jul 29. Review.

12.

Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds.

Li Y, Wicha MS, Schwartz SJ, Sun D.

J Nutr Biochem. 2011 Sep;22(9):799-806. doi: 10.1016/j.jnutbio.2010.11.001. Epub 2011 Feb 4. Review.

13.

Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.

Zhang W, Sviripa V, Kril LM, Chen X, Yu T, Shi J, Rychahou P, Evers BM, Watt DS, Liu C.

J Med Chem. 2011 Mar 10;54(5):1288-97. doi: 10.1021/jm101248v. Epub 2011 Feb 3.

14.

Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.

Kovacic P, Somanathan R.

Oxid Med Cell Longev. 2010 Mar-Apr;3(2):86-100. doi: 10.4161/oxim.3.2.11147. Review.

15.

The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer.

Sarkar FH, Li Y, Wang Z, Kong D.

Cancer Metastasis Rev. 2010 Sep;29(3):383-94. doi: 10.1007/s10555-010-9233-4. Review.

16.

Cancer stem cells: a novel paradigm for cancer prevention and treatment.

Subramaniam D, Ramalingam S, Houchen CW, Anant S.

Mini Rev Med Chem. 2010 May;10(5):359-71. Review.

17.

Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70.

Banerjee Mustafi S, Chakraborty PK, Raha S.

PLoS One. 2010 Jan 14;5(1):e8719. doi: 10.1371/journal.pone.0008719.

18.

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.

Roccaro AM, Ghobrial IM, Blotta S, Treon SP, Malagola M, Anderson KC, Richardson PG, Russo D.

Biologics. 2008 Sep;2(3):419-31.

19.

Cellular signaling perturbation by natural products.

Sarkar FH, Li Y, Wang Z, Kong D.

Cell Signal. 2009 Nov;21(11):1541-7. doi: 10.1016/j.cellsig.2009.03.009. Epub 2009 Mar 16. Review.

20.

Update on therapeutic options in Waldenstr├Âm macroglobulinemia.

Leleu X, Gay J, Roccaro AM, Moreau AS, Poulain S, Dulery R, Champs BB, Robu D, Ghobrial IM.

Eur J Haematol. 2009 Jan;82(1):1-12. doi: 10.1111/j.1600-0609.2008.01171.x. Review.

Supplemental Content

Support Center